Best Interventional Cardiologists in Michigan

DMC Harper University Hospital, Warren, MI | Transcatheter valve therapy, cardiogenic shock, coronary intervention

Theodore Schreiber practices at DMC Harper University Hospital and holds affiliations at Corewell Health East (Beaumont Royal Oak) and Henry Ford Health West Bloomfield. His work spans transcatheter valve procedures, mechanical circulatory support in cardiogenic shock, and coronary atherectomy — the technique of physically removing calcified plaque before stenting.

Dr. Schreiber contributed to the 2014 Journal of the American College of Cardiology study on transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients at extreme surgical risk, which showed the procedure could be performed safely in patients previously considered too fragile for open heart surgery ¹. He was also part of the Detroit Cardiogenic Shock Initiative, a regional protocol that demonstrated how early mechanical circulatory support — placing a device to help the heart pump before it fully fails — could improve survival in patients who arrive with a heart attack complicated by cardiogenic shock ². That paper, published in Catheterization and Cardiovascular Interventions in 2017, found that coordinated regional protocols could cut door-to-support times and improve outcomes. He also contributed to the BOAT trial, which compared balloon angioplasty to directional coronary atherectomy and helped define when more aggressive plaque removal is worthwhile ³.

Research contributions: 247 works, h-index 46 ¹²³⁴⁵

Corewell Health William Beaumont University Hospital, Berkley, MI | Cardiac imaging, pulmonary vascular disease, interventional cardiology

Amr Abbas is Professor of Internal Medicine at Oakland University William Beaumont School of Medicine and practices at Corewell Health William Beaumont University Hospital in Berkley and at Beaumont Hospital Troy. His published research focuses on using echocardiography — ultrasound imaging of the heart — to assess pulmonary vascular resistance and pulmonary hypertension without invasive testing.

A 2003 paper he led in JACC introduced a simple noninvasive method for estimating pulmonary vascular resistance from echocardiographic measurements, citing 641 times since ⁶. For patients being evaluated for pulmonary hypertension before an interventional procedure, this kind of noninvasive assessment can reduce the need for right heart catheterization in some cases. A 2013 follow-up he led in the Journal of the American Society of Echocardiography refined the Doppler-based approach to measuring pulmonary vascular resistance, which influences how patients with pulmonary hypertension are stratified before procedures ⁷. Dr. Abbas has also published on cardiovascular changes during pregnancy and on rare structural conditions such as congenital absence of the pericardium ⁸⁹¹⁰.

Research contributions: 241 works, h-index 33 ⁶⁷⁸⁹¹⁰

Henry Ford Hospital, Detroit, MI | Peripheral artery disease, renal denervation, coronary artery disease

Herbert Aronow is Medical Director of the Heart and Vascular Service Line at Henry Ford Health and holds the Benson Ford Chair in Cardiology. He is also a Professor at Michigan State University College of Human Medicine. He practices at Henry Ford Hospital in Detroit, Henry Ford Health West Bloomfield, and Henry Ford Wyandotte Hospital. His research covers peripheral artery disease, catheter-based hypertension treatment, and the management of patients after acute coronary syndromes.

Dr. Aronow contributed to the SPYRAL HTN-OFF MED Pivotal trial, a 2020 Lancet study that tested catheter-based renal denervation — a procedure that uses radiofrequency energy to reduce nerve activity around the renal arteries as a treatment for uncontrolled hypertension — in patients not taking any blood pressure medications ¹¹. The trial found that renal denervation produced meaningful blood pressure reductions compared to a sham procedure. He was also among the authors of the 2024 ACC/AHA guideline for the management of lower extremity peripheral artery disease, published simultaneously in Circulation and JACC, which sets the current standard for how PAD is diagnosed and treated ¹²¹⁵. For patients with leg artery disease, that guideline directly informs what your doctor should be offering. An earlier Lancet study he led in 2001 examined the effect of early statin therapy after acute coronary syndrome on mortality — a finding that supported the now-standard practice of starting statins immediately after a heart attack ¹⁴.

Research contributions: 429 works, h-index 48 ^1112131415

Corewell Health East (Beaumont Royal Oak), Royal Oak, MI | Coronary physiology, catheter-directed thrombolysis, vascular interventions

Terry Bowers practices at Corewell Health East (Beaumont Royal Oak) and Beaumont Hospital Troy. His published research includes work on coronary blood flow measurement and catheter-directed treatment of pulmonary embolism.

An early paper he contributed to in Catheterization and Cardiovascular Diagnosis in 1993 compared a then-new Doppler guide wire to an established Doppler catheter for measuring coronary blood flow velocity and coronary flow reserve — measurements used during procedures to determine whether a blockage is genuinely limiting blood flow and warrants intervention ¹⁹. He also contributed to a 2019 Vascular Medicine study comparing ultrasound-accelerated thrombolysis to standard catheter-directed thrombolysis for pulmonary embolism treatment, which analyzed outcomes in 98 cases treated at a single institution ¹⁸.

Research contributions: 50 works, h-index 15 ¹⁷¹⁸¹⁹

Trinity Health Oakland Hospital, Bloomfield Hills, MI | Interventional cardiology, structural heart, catheter-directed procedures

Michele Degregorio practices at Trinity Health Oakland Hospital in Bloomfield Hills, with additional affiliations at Corewell Health East (Beaumont Royal Oak) and McLaren Oakland. His published case reports cover unusual presentations of structural and vascular problems encountered during catheter-based procedures.

Published case work includes a 2019 JACC Case Reports paper describing successful catheter-directed thrombolysis in a patient with massive bilateral upper extremity deep vein thrombosis presenting as superior vena cava syndrome — a condition where standard anticoagulation, angioplasty, and thrombectomy had all failed before ultrasound-assisted thrombolysis resolved it ²². He has also published on rare diagnostic findings encountered in catheterization, including a late-presenting case of Scimitar syndrome (a congenital pulmonary venous anomaly diagnosed in a 70-year-old woman) and on cardiac metastasis presenting as ST-elevation on ECG ²⁰²¹²³.

Research contributions: 27 works, h-index 6 ^2021222324

Michigan Medicine, Taubman Center, Ann Arbor, MI | Vascular biology, coronary artery disease, cardiac risk

Peter Farrehi practices at Michigan Medicine in Ann Arbor. His research background is in vascular biology, specifically the role of plasminogen activator inhibitor-1 (PAI-1) in arterial thrombosis and restenosis after vascular injury — mechanisms relevant to what happens to blood vessels after catheter-based procedures.

A 1998 Circulation paper he led showed that PAI-1, a protein that inhibits the body's clot-dissolving system, is an important determinant of thrombolysis at sites of arterial injury in a mouse model ²⁵. A follow-up 2001 Circulation study from the same line of research found that PAI-1 promotes neointima formation — the regrowth of tissue inside a vessel after injury — in atherosclerosis-prone mice, suggesting a mechanism for why some patients develop restenosis after coronary procedures ²⁶. He has also published on the frequency of negative findings on coronary angiography in chest pain patients in southeastern Michigan hospitals, and on the interaction between electrosurgery and implantable cardiac devices ²⁷²⁸²⁹.

Research contributions: 42 works, h-index 13 ^2526272829